Boston Scientific Corp. (BSX) - Get Report is expected to report net income of $541 million, or 38 cents a share, on sales of $2.6 billion before the market opens on Wednesday, based on a FactSet survey of 22 analysts.
In the same period a year ago, the company posted earnings of 35 cents a share on sales of $2.4 billion. It reported net income of $555 million.
The company offered EPS guidance of 37 cents to 39 cents a share at the time of its last earnings report on July 24. Shares have fallen 9.8% since then.
Quarterly estimates have risen less than 1 cent a share in the past month.
In the upcoming quarter, analysts are forecasting net income of $626.8 million, or 44 cents a share, on sales of $2.9 billion.
Boston Scientific is currently trading at a price-to-forward-earnings ratio of 21.9 based on the 12-month estimates of 22 analysts surveyed by FactSet.
Save 57% during our Halloween Sale. Don't let this market haunt you. Join Jim Cramer's Investment Club, Action Alerts PLUS. Click here to sign up!
Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.